206 related articles for article (PubMed ID: 21422499)
41. Balancing Protein Stability and Activity in Cancer: A New Approach for Identifying Driver Mutations Affecting CBL Ubiquitin Ligase Activation.
Li M; Kales SC; Ma K; Shoemaker BA; Crespo-Barreto J; Cangelosi AL; Lipkowitz S; Panchenko AR
Cancer Res; 2016 Feb; 76(3):561-71. PubMed ID: 26676746
[TBL] [Abstract][Full Text] [Related]
42. Dasatinib targets B-lineage cells but does not provide an effective therapy for myeloproliferative disease in c-Cbl RING finger mutant mice.
Duyvestyn JM; Taylor SJ; Dagger SA; Orandle M; Morse HC; Thien CB; Langdon WY
PLoS One; 2014; 9(4):e94717. PubMed ID: 24718698
[TBL] [Abstract][Full Text] [Related]
43. Cbl-family proteins as regulators of cytoskeleton-dependent phenomena.
Lee H; Tsygankov AY
J Cell Physiol; 2013 Dec; 228(12):2285-93. PubMed ID: 23744514
[TBL] [Abstract][Full Text] [Related]
44. CIN85 is required for Cbl-mediated regulation of antigen receptor signaling in human B cells.
Niiro H; Jabbarzadeh-Tabrizi S; Kikushige Y; Shima T; Noda K; Ota S; Tsuzuki H; Inoue Y; Arinobu Y; Iwasaki H; Shimoda S; Baba E; Tsukamoto H; Horiuchi T; Taniyama T; Akashi K
Blood; 2012 Mar; 119(10):2263-73. PubMed ID: 22262777
[TBL] [Abstract][Full Text] [Related]
45. Mutations of the TET2 and CBL genes: novel molecular markers in myeloid malignancies.
Bacher U; Haferlach C; Schnittger S; Kohlmann A; Kern W; Haferlach T
Ann Hematol; 2010 Jul; 89(7):643-52. PubMed ID: 20195608
[TBL] [Abstract][Full Text] [Related]
46. Structural Determinants of the Gain-of-Function Phenotype of Human Leukemia-associated Mutant CBL Oncogene.
Nadeau SA; An W; Mohapatra BC; Mushtaq I; Bielecki TA; Luan H; Zutshi N; Ahmad G; Storck MD; Sanada M; Ogawa S; Band V; Band H
J Biol Chem; 2017 Mar; 292(9):3666-3682. PubMed ID: 28082680
[TBL] [Abstract][Full Text] [Related]
47. PTK6 promotes degradation of c-Cbl through PTK6-mediated phosphorylation.
Kang SA; Lee ST
Biochem Biophys Res Commun; 2013 Feb; 431(4):734-9. PubMed ID: 23352614
[TBL] [Abstract][Full Text] [Related]
48. E3 ubiquitin ligase-mediated regulation of bone formation and tumorigenesis.
Sévère N; Dieudonné FX; Marie PJ
Cell Death Dis; 2013 Jan; 4(1):e463. PubMed ID: 23328670
[TBL] [Abstract][Full Text] [Related]
49. Juvenile myelomonocytic leukemia due to a germline CBL Y371C mutation: 35-year follow-up of a large family.
Pathak A; Pemov A; McMaster ML; Dewan R; Ravichandran S; Pak E; Dutra A; Lee HJ; Vogt A; Zhang X; Yeager M; Anderson S; Kirby M; ; ; Caporaso N; Greene MH; Goldin LR; Stewart DR
Hum Genet; 2015 Jul; 134(7):775-87. PubMed ID: 25939664
[TBL] [Abstract][Full Text] [Related]
50. Indispensable roles of mammalian Cbl family proteins as negative regulators of protein tyrosine kinase signaling: Insights from in vivo models.
Naramura M; Band V; Band H
Commun Integr Biol; 2011 Mar; 4(2):159-62. PubMed ID: 21655429
[TBL] [Abstract][Full Text] [Related]
51. Differential expression and signaling of CBL and CBL-B in BCR/ABL transformed cells.
Sattler M; Pride YB; Quinnan LR; Verma S; Malouf NA; Husson H; Salgia R; Lipkowitz S; Griffin JD
Oncogene; 2002 Feb; 21(9):1423-33. PubMed ID: 11857085
[TBL] [Abstract][Full Text] [Related]
52. Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms.
Grand FH; Hidalgo-Curtis CE; Ernst T; Zoi K; Zoi C; McGuire C; Kreil S; Jones A; Score J; Metzgeroth G; Oscier D; Hall A; Brandts C; Serve H; Reiter A; Chase AJ; Cross NC
Blood; 2009 Jun; 113(24):6182-92. PubMed ID: 19387008
[TBL] [Abstract][Full Text] [Related]
53. Phosphotyrosine binding domain-dependent upregulation of the platelet-derived growth factor receptor alpha signaling cascade by transforming mutants of Cbl: implications for Cbl's function and oncogenicity.
Bonita DP; Miyake S; Lupher ML; Langdon WY; Band H
Mol Cell Biol; 1997 Aug; 17(8):4597-610. PubMed ID: 9234717
[TBL] [Abstract][Full Text] [Related]
54. The role of the JAK2 GGCC haplotype and the TET2 gene in familial myeloproliferative neoplasms.
Olcaydu D; Rumi E; Harutyunyan A; Passamonti F; Pietra D; Pascutto C; Berg T; Jäger R; Hammond E; Cazzola M; Kralovics R
Haematologica; 2011 Mar; 96(3):367-74. PubMed ID: 21173100
[TBL] [Abstract][Full Text] [Related]
55. Cbl negatively regulates erythropoietin-induced growth and survival signaling through the proteasomal degradation of Src kinase.
Shintani T; Ohara-Waki F; Kitanaka A; Tanaka T; Kubota Y
Blood Cells Mol Dis; 2014 Dec; 53(4):211-8. PubMed ID: 25084697
[TBL] [Abstract][Full Text] [Related]
56. Mechanism underlying the development of myeloproliferative neoplasms through mutant calreticulin.
Edahiro Y; Araki M; Komatsu N
Cancer Sci; 2020 Aug; 111(8):2682-2688. PubMed ID: 32462673
[TBL] [Abstract][Full Text] [Related]
57. Erbin interacts with c-Cbl and promotes tumourigenesis and tumour growth in colorectal cancer by preventing c-Cbl-mediated ubiquitination and down-regulation of EGFR.
Yao S; Zheng P; Wu H; Song LM; Ying XF; Xing C; Li Y; Xiao ZQ; Zhou XN; Shen T; Chen L; Liu YH; Lai MD; Mei L; Gao TM; Li JM
J Pathol; 2015 May; 236(1):65-77. PubMed ID: 25521828
[TBL] [Abstract][Full Text] [Related]
58. SH2B3 (LNK) mutations from myeloproliferative neoplasms patients have mild loss of function against wild type JAK2 and JAK2 V617F.
Koren-Michowitz M; Gery S; Tabayashi T; Lin D; Alvarez R; Nagler A; Koeffler HP
Br J Haematol; 2013 Jun; 161(6):811-20. PubMed ID: 23590807
[TBL] [Abstract][Full Text] [Related]
59. Heterozygous germline mutations in the CBL tumor-suppressor gene cause a Noonan syndrome-like phenotype.
Martinelli S; De Luca A; Stellacci E; Rossi C; Checquolo S; Lepri F; Caputo V; Silvano M; Buscherini F; Consoli F; Ferrara G; Digilio MC; Cavaliere ML; van Hagen JM; Zampino G; van der Burgt I; Ferrero GB; Mazzanti L; Screpanti I; Yntema HG; Nillesen WM; Savarirayan R; Zenker M; Dallapiccola B; Gelb BD; Tartaglia M
Am J Hum Genet; 2010 Aug; 87(2):250-7. PubMed ID: 20619386
[TBL] [Abstract][Full Text] [Related]
60. As4S4 targets RING-type E3 ligase c-CBL to induce degradation of BCR-ABL in chronic myelogenous leukemia.
Mao JH; Sun XY; Liu JX; Zhang QY; Liu P; Huang QH; Li KK; Chen Q; Chen Z; Chen SJ
Proc Natl Acad Sci U S A; 2010 Dec; 107(50):21683-8. PubMed ID: 21118980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
